Early-life exposure to antibiotics increases the risk of myopia: A retrospective cohort study

Peng-Tai Tien1,2, Chang-Ching Wei3,4, Sheng-Chun Lin5

  • 1Eye Center, China Medical University Hospital, China Medical University, Taichung 40447, Taiwan.

Biomedicine
|July 22, 2026
PubMed
Abstract

Insights

Early childhood antibiotic use increases myopia risk in children. This study highlights the need for careful antibiotic prescribing to protect long-term vision and prevent myopia progression.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Pediatrics

Background:

  • Myopia prevalence is rising globally, with environmental factors playing a key role.
  • Early-life antibiotic exposure can alter gut microbiota, potentially impacting ocular health.
  • Infant and early childhood antibiotic use is common and may influence myopia development.

Purpose of the Study:

  • To investigate the association between early-life antibiotic exposure and the incidence of myopia in young children.
  • To quantify the risk of myopia associated with systemic antibiotic use in children aged three years or younger.

Main Methods:

  • Retrospective cohort study using a national health insurance database.
  • Matched antibiotic-exposed children (≤3 years old) with non-exposed controls.
  • Cox proportional hazards regression models to estimate myopia risk (aHRs).

Main Results:

  • Early-life antibiotic exposure significantly increased myopia risk (aHR = 1.03; 95% CI: 1.02-1.04).
  • Higher cumulative incidence of myopia observed in antibiotic-exposed children (p < 0.001).
  • Increased risk persisted regardless of treatment duration or cumulative dose.

Conclusions:

  • Early-life antibiotic exposure is linked to a higher incidence of myopia in children.
  • Judicious antibiotic prescribing in early childhood is crucial to mitigate potential ocular health risks.
  • Findings emphasize the importance of considering long-term consequences of antibiotic use on vision development.

Related Concept Videos

Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...